91制片厂

听

Table 1听听听听听听听听听听听 Sales of Advate/Recombinate
Table 2听听听听听听听听听听听 Sales of Kogenate (FS)
Table 3听听听听听听听听听听听 Sales of Helixate (NexGen)
Table 4听听听听听听听听听听听 Sales of ReFacto (AF)/Xyntha
Table 5听听听听听听听听听听听 Growth of the Recombinant Factor VIII Market
Table 6听听听听听听听听听听听 Market Shares of Recombinant Factor VIII Products
Table 7听听听听听听听听听听听 Sales of BeneFIX / Growth of rFIX Market
Table 8听听听听听听听听听听听 Sales of NovoSeven
Table 9听听听听听听听听听听听 Sales of Coagil VII
Table 10听听听听听听听听听 Growth of Recombinant Factor VIIa Market
Table 11听听听听听听听听听 Sales of Recothrom
Table 12听听听听听听听听听 Total Market Size of Recombinant Coagulation Factors in Hemophilia
Table 13听听听听听听听听听 The US/EU Clinical Trial Program of GreenGene F
Table 14听听听听听听听听听 The Clinical Trial Program of Nuwiq (simoctocog alfa)
Table 15听听听听听听听听听 The LEOPOLD Clinical Trial Program of BAY 81-8973
Table 16听听听听听听听听听 The AFFINITY Clinical Trial Program of CSL627
Table 17听听听听听听听听听 The Clinical Trial Program of Eloctate
Table 18听听听听听听听听听 The Clinical Trial Program of BAX 855
Table 19听听听听听听听听听 The Clinical Trial Program of damoctocog alfa pegol
Table 20听听听听听听听听听 The PATHFINDER Clinical Trial Program of turoctocog alfa pegol
Table 21听听听听听听听听听 The Clinical Trial Program of nonacog gamma
Table 22听听听听听听听听听 The Clinical Trial Program of trenonacog alfa
Table 23听听听听听听听听听 The Clinical Trial Program of Alprolix
Table 24听听听听听听听听听 The PROLONG-9FP Clinical Trial Program of CSL654
Table 25听听听听听听听听听 The PARADIGM Clinical Trial Program of nonacog beta pegol
Table 26听听听听听听听听听 The Clinical Trial Program of BAX 817
Table 27听听听听听听听听听 The PERSEPT Clinical Trial Program of LR769
Table 28听听听听听听听听听 The PROLONG-7FP Clinical Trial Program of CSL689
Table 29听听听听听听听听听 R&D Stage and Timeline of wild-type, improved and biosimilar rFVIII
Table 30听听听听听听听听听 Inhibitor Formation by wild-type and improved rFVIII
Table 31听听听听听听听听听 Half-Life and Dosing Frequency of wild-type and improved rFVIII
Table 32听听听听听听听听听 Efficacy of wild-type and improved rFVIII
Table 33听听听听听听听听听 R&D Stage and Timeline of Long-Acting rFVIII
Table 34听听听听听听听听听 Inhibitor Formation by Long-Acting rFVIII
Table 35听听听听听听听听听 Half-Life and Dosing Frequency of Long-Acting rFVIII
Table 36听听听听听听听听听 Efficacy of Long-Acting rFVIII
Table 37听听听听听听听听听 R&D Stage and Timeline of wild-type, biosimilar and long-acting rFIX
Table 38听听听听听听听听听 Inhibitor Formation by rFIX
Table 39听听听听听听听听听 Half-Life and Dosing Frequency of rFIX
Table 40听听听听听听听听听 Efficacy of rFIX
Table 41听听听听听听听听听 R&D Stage and Timeline of wild-type, biosimlar and long-acting rFVII
Table 42听听听听听听听听听 Inhibitor Formation by wild-type and long-acting rFVII
Table 43听听听听听听听听听 Half-Life and Dosing Frequency of wild-type and long-acting rFVII
Table 44听听听听听听听听听 Other Recombinant Coagulation Factors
Table 45听听听听听听听听听 R&D Stage and Timelines of Alternative Procoagulants
Table 46听听听听听听听听听 Product Profiles of Systemic Alternative Procoagulants
Table 47听听听听听听听听听 R&D Stage and Timeline of Gene Therapy of Hemophilia B
Table 48听听听听听听听听听 R&D Stage and Timeline of Gene & Cell Therapy of Hemophilia A
Table 49听听听听听听听听听 R&D Stage and Timeline of Gene Therapy of Hemophilia A and B
Table 50听听听听听听听听听 Immune Tolerance Inducing (ITI) Agents
Table 51听听听听听听听听听 Baxter Hemophilia Recombinant Product Portfolio and R&D Pipeline听
Table 52听听听听听听听听听 Novo Nordisk Bleeding Disorder Product Portfolio and R&D Pipeline
Table 53听听听听听听听听听 CSL Hemophilia Recombinant Product Portfolio and R&D Pipeline
Table 54听听听听听听听听听 Bayer Hemophilia Product Portfolio and R&D Pipeline
Table 55听听听听听听听听听 Pfizer Bleeding Disorder Recombinant Products and R&D Pipeline
Table 56听听听听听听听听听 Octapharma Hemophilia Recombinant Product Portfolio
Table 57听听听听听听听听听 LFB Hemophilia Recombinant R&D Pipeline
Table 58听听听听听听听听听 The Medicines Company Bleeding Disorder Product and R&D Pipeline
Table 59听听听听听听听听听 Biogen Idec Hemophilia Recombinant Products and R&D Pipeline
Table 60听听听听听听听听听 AstraZeneca Hemophilia & Bleeding Disorder R&D Pipeline
Table 61听听听听听听听听听 Shire and Sangamo Biosciences Bleeding Disorder R&D Pipeline
Table 62听听听听听听听听听 BioMarin Pharmaceutical Hemophilia R&D Pipeline
Table 63听听听听听听听听听 Emergent BioSolutions Hemophilia R&D Pipeline
Table 64听听听听听听听听听 OPKO Health Hemophilia R&D Pipeline
Table 65听听听听听听听听听 Generium Hemophilia Product Portfolio and R&D Pipeline
Table 66听听听听听听听听听 Catalyst Biosciences Bleeding Disorder Recombinant R&D Pipeline
Table 67听听听听听听听听听 Pharming Hemophilia & Bleeding Disorder R&D Pipeline
Table 68听听听听听听听听听 uniQure Hemophilia R&D Pipeline
Table 69听听听听听听听听听 Spark Therapeutics Hemophilia R&D Pipeline
Table 70听听听听听听听听听 Dimension Therapeutics Hemophilia R&D Pipeline
Table 71听听听听听听听听听 Expression Therapeutics Hemophilia R&D Pipeline
Table 72听听听听听听听听听 ReGenX Biosciences Hemophilia R&D Pipeline
Table 73听听听听听听听听听 Sernova & Medicyte Hemophilia R&D Pipeline
Table 74听听听听听听听听听 Pipeline Overview and R&D Trends
Table 75听听听听听听听听听 Target Launch Years for Novel rFVIII Molecules by Company Names
Table 76听听听听听听听听听 Target Launch Years for Novel rFIX Molecules by Company Names
Table 77听听听听听听听听听 Major Players and Hemophilia Portfolio Coverage